- Previous Close
0.0000 - Open
0.0015 - Bid --
- Ask --
- Day's Range
0.0015 - 0.0015 - 52 Week Range
0.0002 - 0.0015 - Volume
200,000 - Avg. Volume
377 - Market Cap (intraday)
41,980 - Beta (5Y Monthly) 1.64
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Sangui Biotech International, Inc., through its subsidiaries, engages in the manufacturing and sales of wound treatment and cosmetic products. The company offers artificial oxygen carriers comprising oxygen carrying blood additives and oxygen carrying blood volume substitutes; nano formulations for the regeneration of skin; chitoskin wound pads; Hemospray, a hemoglobin based wound spray; and wound dressing spray under the Granulox brand. Sangui Biotech International, Inc. was incorporated in 1995 and is headquartered in Hamburg, Germany.
www.sanguibiotech.com--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: SGBI
View MorePerformance Overview: SGBI
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SGBI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SGBI
View MoreValuation Measures
Market Cap
41.98k
Enterprise Value
869.05k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.52
Price/Book (mrq)
--
Enterprise Value/Revenue
10.75
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
51.91%
Return on Assets (ttm)
54.89%
Return on Equity (ttm)
--
Revenue (ttm)
269.8k
Net Income Avi to Common (ttm)
140.05k
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
7.71k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
24.99k